ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,708Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 761

$619K Total Retail Price of All Prescriptions

Rank: 66 out of 761

604 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 604 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 604 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 10,261 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 666 642 1 2
LEVOTHYROXINE SODIUM 527 524 2 3
ATENOLOL 401 396 3 8
LOSARTAN POTASSIUM 399 393 4 13
OMEPRAZOLE 321 307 5 4
LISINOPRIL 297 293 6 1
AMLODIPINE BESYLATE 284 283 7 6
FUROSEMIDE 243 240 8 7
HYDROCODONE-ACETAMINOPHEN 234 198 S3 9 5
ATORVASTATIN CALCIUM 229 211 10 12
POTASSIUM CHLORIDE 226 217 11 18
ZOLPIDEM TARTRATE 216 211 12 22
GABAPENTIN 215 210 13 15
WARFARIN SODIUM 211 208 14 9
METFORMIN HCL 208 202 15 10
METOPROLOL SUCCINATE 173 165 16 16
LOVASTATIN 146 140 17 17
HYDROCHLOROTHIAZIDE 141 138 18 11
LOSARTAN-HYDROCHLOROTHIAZIDE 130 128 19 65
METOPROLOL TARTRATE 116 111 20 14
CITALOPRAM HBR 115 106 21 19
MELOXICAM 113 108 22 61
AZITHROMYCIN 109 101 23 70
ROPINIROLE HCL 108 103 24 95
PRAVASTATIN SODIUM 95 91 25 20
KLOR-CON M20 94 94 26 99
ALENDRONATE SODIUM 91 85 27 21
PAROXETINE HCL 89 80 28 47
SERTRALINE HCL 84 82 29 25
CARVEDILOL 83 83 30 26
CLOPIDOGREL 80 78 31 66
ZETIA 80 80 31 87
SYNTHROID 79 79 33 64
ALLOPURINOL 75 75 34 28
TAMSULOSIN HCL 73 66 35 27
DONEPEZIL HCL 70 70 36 33
CRESTOR 67 62 37 36
VYTORIN 66 66 38 168
TRIAMTERENE-HCTZ 57 48 39 42
BENICAR 57 57 39 81
TERAZOSIN HCL 56 51 41 86
TRAZODONE HCL 55 44 42 23
FLUTICASONE PROPIONATE 55 54 42 29
MIRTAZAPINE 54 54 44 50
CYMBALTA 54 53 44 53
GLIPIZIDE ER 54 54 44 124
PANTOPRAZOLE SODIUM 52 48 47 40
PROAIR HFA 51 45 48 32
PREMARIN 50 50 R 49 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.